產(chǎn)品詳情

  • 產(chǎn)品名稱：MatrixGlaProtein(MGP)(MiddleRegion)Peptide

  • 產(chǎn)品型號(hào)：
  • 產(chǎn)品廠商：半導(dǎo)體
  • 產(chǎn)品文檔：
你添加了1件商品 查看購(gòu)物車
簡(jiǎn)單介紹：
MatrixGlaProtein(MGP)(MiddleRegion)Peptide
詳情介紹：
Blocked Antibody anti-Matrix Gla Protein (MGP) (Middle Region) antibody (ABIN2784506)
Characteristics This is a synthetic peptide designed for use in combination with anti-MGP antibody (Catalog #: ARP51308_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
Purification Purified
Background MGP is associates with the organic matrix of bone and cartilage. MGP is thought to act as an inhibitor of bone formation.

Alias Symbols: GIG36, MGLAP, NTI

Protein Interaction Partner: BMP2,BMP2

Protein Size: 103
Molecular Weight 12 kDa
Gene ID 4256
NCBI Accession NM_000900, NP_000891
UniProt P08493
Research Area Signaling, Extracellular Matrix
Application Notes Each Investigator should determine their own optimal working dilution for specific applications.
Restrictions For Research Use only
Format Lyophilized
Reconstitution Add 100?μL of sterile PBS. Final peptide concentration is 1?mg/mL in PBS.
Concentration 1 mg/mL
Buffer Final peptide concentration is 1 mg/mL in PBS.
Handling Advice Avoid repeated freeze-thaw cycles.
Storage -20 °C
Storage Comment For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.